Watchlist Price Alert

Amicus Therapeutics Inc. (FOLD)

NASDAQ: FOLD · Real-Time Price · USD

6.12

-0.04 (-0.65%)

At close: Jun 09, 2025, 10:40 AM

Amicus Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Cash & Equivalents	213.75M	246.99M	148.81M	245.2M	163.24M	142.84M	79.75M	49.06M	187.03M
Short-Term Investments	36.19M	39.21M	144.78M	237.3M	320.03M	309.9M	424.4M	309.5M	143.32M
Long-Term Investments	n/a	n/a	4.3M	-4.93M	-4.9M	-5.05M	-6.46M	-6.46M	-173.77M
Other Long-Term Assets	13.64M	18.55M	10M	24.43M	19.09M	28.32M	6.68M	5.2M	2.47M
Receivables	101.1M	87.63M	66.2M	52.67M	46.92M	33.28M	21.96M	9.46M	1.3M
Inventory	118.78M	59.7M	23.82M	26.82M	19.56M	14.04M	8.39M	4.62M	3.42M
Other Current Assets	34.91M	49.53M	40.21M	34.85M	29.72M	20.01M	16.59M	19.32M	4.99M
Total Current Assets	504.74M	483.06M	423.82M	596.83M	579.47M	520.07M	551.1M	391.96M	340.06M
Property-Plant & Equipment	51.66M	57.98M	60.31M	63.08M	67.16M	81.02M	11.38M	9.06M	9.82M
Goodwill & Intangibles	215M	218.29M	220.8M	220.8M	220.8M	220.8M	220.8M	220.8M	684.5M
Total Long-Term Assets	280.3M	294.82M	300.35M	308.31M	307.05M	330.13M	238.85M	235.06M	696.78M
Total Assets	785.03M	777.88M	724.17M	905.14M	886.52M	850.21M	789.95M	627.02M	1.04B
Account Payables	12.95M	15.12M	15.41M	21.51M	17.06M	21.72M	6.61M	7.87M	12.9M
Deferred Revenue	n/a	n/a	4.94M	n/a	1.5M	1.25M	5.5M	7.75M	69.4M
Short-Term Debt	8.46M	n/a	8.55M	7.41M	6.87M	7.19M	n/a	n/a	n/a
Other Current Liabilities	109.19M	93.51M	74.86M	79.23M	64.67M	53.06M	32.06M	30.82M	23.8M
Total Current Liabilities	148.7M	167.69M	139.02M	145.97M	129.68M	128.81M	86.13M	70.04M	110.96M
Long-Term Debt	390.11M	387.86M	443.57M	432.72M	434.86M	149.5M	321.74M	164.17M	154.46M
Other Long-Term Liabilities	52.17M	13.28M	-37.98M	-29.22M	-14.89M	36.88M	32.71M	33.5M	237.5M
Total Long-Term Liabilities	442.29M	450.02M	462.1M	451.8M	470.46M	244.97M	360.91M	204.13M	565.74M
Total Liabilities	590.99M	617.71M	601.12M	597.77M	600.14M	373.78M	447.04M	274.17M	676.69M
Total Debt	443.64M	445.06M	452.12M	440.13M	441.73M	210.22M	321.74M	164.47M	154.46M
Common Stock	2.94M	2.92M	2.81M	2.81M	2.65M	2.6M	1.94M	1.72M	1.48M
Retained Earnings	-2.74B	-2.68B	-2.53B	-2.3B	-2.05B	-1.77B	-1.41B	-1.06B	-779.61M
Comprehensive Income	n/a	5.24M	-12.11M	4.98M	8.23M	2.83M	68K	-2.1M	2.05M
Shareholders Equity	194.04M	160.17M	123.05M	307.37M	286.38M	476.43M	342.91M	352.85M	360.15M
Total Investments	36.19M	39.21M	144.78M	237.3M	320.03M	309.9M	424.4M	309.5M	143.32M